Evidence map›Paper›PMID 33082837›Full record

ArticleComputational and mathematical methods in medicine2020

Mathematical Modelling of HIV-HCV Coinfection Dynamics in Absence of Therapy.

Edison Mayanja, Livingstone S Luboobi, Juma Kasozi, Rebecca N Nsubuga

Abstract read
In one paragraph

Article in Computational and mathematical methods in medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Optimal Control and Bifurcation Analysis of HIV Model.Computational and mathematical methods in medicine · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Edison MayanjaDepartment of Mathematics, Makerere University, P.O. Box 7062, Kampala, Uganda.ORCID https://orcid.org/0000-0002-8077-3083
Livingstone S LuboobiInstitute of Mathematical Sciences (IMS), Strathmore University, P.O. Box 59857-00200, Nairobi, Kenya.
Juma KasoziDepartment of Mathematics, Makerere University, P.O. Box 7062, Kampala, Uganda.
Rebecca N NsubugaIndependent Researcher, Kampala, Uganda.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Globally, it is estimated that of the 36.7 million people infected with human immunodeficiency virus (HIV), 6.3% are coinfected with hepatitis C virus (HCV). Coinfection with HIV reduces the chance of HCV spontaneous clearance. In this work, we formulated and analysed a deterministic model to study the HIV and HCV coinfection dynamics in absence of therapy. Due to chronic stage of HCV infection being long, asymptomatic, and infectious, our model formulation was based on the splitting of the chronic stage into the following: before onset of cirrhosis and its complications and after onset of cirrhosis. We computed the basic reproduction numbers using the next generation matrix method. We performed numerical simulations to support the analytical results. We carried out sensitivity analysis to determine the relative importance of the different parameters influencing the HIV-HCV coinfection dynamics. The findings reveal that, in the long run, there is a substantial number of individuals coinfected with HIV and latent HCV. Therefore, HIV and latently HCV-infected individuals need to seek early treatment so as to slow down the progression of HIV to AIDS and latent HCV to advanced HCV.

Indexed as

Models, BiologicalBasic Reproduction NumberCoinfectionComputational BiologyComputer SimulationDisease ProgressionDisease SusceptibilityFemaleHepatitis C, ChronicHIV InfectionsHumansMaleMathematical Concepts

Identifiers

PMID33082837
PMCPMC7566217

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.